ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,995.69
-1.73%
US Tech 100
20,488.00
-3.29%
다우존스 지수
44,548.08
0.28%
Bitcoin
99,756.29
-4.71%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRB)

  7. Cellectar Biosciences Inc (CLRB) 뉴스

CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CLRB
일자시간출처헤드라인심볼기업
2025/01/1420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2025/01/1308:00GlobeNewswire Inc.Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare ConferenceNASDAQ:CLRBCellectar Biosciences Inc
2024/12/1123:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/12/1107:00GlobeNewswire Inc.Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate RestructuringNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1821:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1821:05GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1820:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1606:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1506:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1506:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1422:05GlobeNewswire Inc.Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1406:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1406:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1222:05GlobeNewswire Inc.Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of CancerNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1206:05GlobeNewswire Inc.Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024NASDAQ:CLRBCellectar Biosciences Inc
2024/11/0720:40GlobeNewswire Inc.Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024NASDAQ:CLRBCellectar Biosciences Inc
2024/11/0206:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/0206:00GlobeNewswire Inc.Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-QNASDAQ:CLRBCellectar Biosciences Inc
2024/10/3006:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
2024/10/3006:03Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/10/3005:56Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/08/2619:40GlobeNewswire Inc.Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
2024/08/2406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/2406:00GlobeNewswire Inc.Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from NasdaqNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1508:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/08/1506:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1319:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1319:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1006:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/0906:15GlobeNewswire Inc.UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
 검색 관련기사 보기:NASDAQ:CLRB

최근 히스토리

COIN
XRPUSD
Ripple
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NYSE
MCD
McDonalds
NYSE
MRK
Merck
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
FX
USDGBP
US Dollar vs Sterling
USI
USTECH100
US Tech 100
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유